Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT04751084
NA

Buscopan in Patients Undergoing IVF/Intracytoplasmic Sperm Injection Treatment

Sponsor: Chinese University of Hong Kong

View on ClinicalTrials.gov

Summary

To determine if the use of Buscopan in patients undergoing IVF/ICSI treatment with high uterine contraction frequency prior to embryo transfer has a higher live birth rate.

Official title: Use of Buscopan in Patients Undergoing IVF/Intracytoplasmic Sperm Injection Treatment With High and Low Uterine Contraction Frequency Prior to Embryo Transfer: A Prospective Double-blinded Randomized Controlled Trial

Key Details

Gender

FEMALE

Age Range

Any - 42 Years

Study Type

INTERVENTIONAL

Enrollment

675

Start Date

2020-05-30

Completion Date

2024-09-14

Last Updated

2024-05-08

Healthy Volunteers

No

Interventions

DRUG

Buscopan 20 milligrams/ML Injectable Solution

cases will be randomized to Buscopan group or Normal Saline group, injection will be given 5 minutes prior to embryo transfer

Locations (1)

Prince of Wales Hospital

Hong Kong, Hong Kong